Anika Therapeutics | ANIK - PE Price to Earnings


Anika Therapeutics reported 47.54 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Halozyme Therapeutics 11.35 11.8 Mar/2026
Integra LifeSciences 5.07 1.52 Mar/2026
Intrexon 7.54 221.44 Dec/2021
J&J 24.53 0.91 Mar/2026
Ligand Pharmaceuticals 56.5 26.8 Mar/2026
Merit Medical Systems 45.2 6.08 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Sanofi 11.84 0.14 Mar/2026
Smith & Nephew 17.63 4.2 Dec/2025
Stryker 30.44 1.69 Mar/2026
Veracyte 24.89 20.41 Mar/2026
Xencor 29.92 3.22 Sep/2022
Zimmer Biomet Holdings 25.47 7.56 Mar/2026